NIP
ANAB icon

Nicholas Investment Partners’s AnaptysBio ANAB Stock Holding History

Nicholas Investment Partners’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-29,897
Closed -$2.98M – 213
2018
Q3 		$2.98M Sell
29,897
-518
-2% -$43K 0.24% 161
2018
Q2 		$2.16M Buy
30,415
+3,197
+12% +$268K 0.15% 183
2018
Q1 		$2.83M Sell
27,218
-11,205
-29% -$1.26M 0.2% 163
2017
Q4 		$3.87M Buy
+38,423
New +$2.83M 0.26% 126

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nicholas Investment Partners's ANAB Position: Q4 2018 in Review

Nicholas Investment Partners sold out of AnaptysBio (ANAB) in Q4 2018, closing a stake of 29,897 shares — an estimated $2.98M sold.

Nicholas Investment Partners first reported a position in ANAB in Q4 2017 and held it in 4 quarters. The position peaked at $3.87M in Q4 2017. 121 funds tracked by Wall St. Rank hold ANAB as of Q4 2018.

  • Nicholas Investment Partners reported no remaining AnaptysBio position as of Q4 2018 after selling out during the quarter.
  • Nicholas Investment Partners sold 29,897 AnaptysBio shares in Q4 2018, an estimated $2.98M.
  • Nicholas Investment Partners first reported a position in AnaptysBio in Q4 2017 and held it in 4 quarters.
  • Nicholas Investment Partners's AnaptysBio position peaked at $3.87M in Q4 2017.
  • 121 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2018.

Based on Nicholas Investment Partners's 13F filing for Q4 2018, filed 14 Feb 2019.